National Institute For Medical Research

National Institute For Medical Research The National Institute for Medical Research (NIMR) is a government research institution under the Ministry for Health established in 1979.

NIMR has the dual mandate to conduct and regulate health research on Tanzania Mainland. The National Institute for Medical Research (NIMR) is the largest public health research institution in Tanzania. It was established by the Parliament Act No. 23 of 1979 as a parastatal organization under the Ministry of Health. The establishment of NIMR was in recognition by the government of the need to generate scientific information required in the development of better methods and techniques of enhancing disease management, prevention and control in the country.

๐—•๐—ฒ๐˜†๐—ผ๐—ป๐—ฑ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ช๐—ฎ๐˜€๐˜๐—ฒ๐˜„๐—ฎ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ป๐˜ƒ๐—ถ๐—ฟ๐—ผ๐—ป๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐— ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐˜ƒ๐—ฒ๐—ฎ๐—น ๐—›๐—ผ๐˜๐˜€๐—ฝ๐—ผ๐˜๐˜€ ๐—ผ๐—ณ ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น-๐—ฅ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ โ€œ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐—ฏ...
12/12/2025

๐—•๐—ฒ๐˜†๐—ผ๐—ป๐—ฑ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐—ถ๐—น๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ช๐—ฎ๐˜€๐˜๐—ฒ๐˜„๐—ฎ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ป๐˜ƒ๐—ถ๐—ฟ๐—ผ๐—ป๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐— ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐˜ƒ๐—ฒ๐—ฎ๐—น ๐—›๐—ผ๐˜๐˜€๐—ฝ๐—ผ๐˜๐˜€ ๐—ผ๐—ณ ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น-๐—ฅ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ โ€œ๐—ฆ๐˜‚๐—ฝ๐—ฒ๐—ฟ๐—ฏ๐˜‚๐—ด๐˜€โ€

A recent study presented at the 7th Africa Continental World Antimicrobial Awareness Week (WAAW) event has unveiled the โ€œenvironmental resistomeโ€ in Tanzania. Using advanced genomic tools to analyse wastewater and environmental surveillance (WES) from Dar es Salaam and Tanga, pilot sites where the project is being implemented, the study's preliminary results provide a population-level snapshot of circulating antimicrobial resistance (AMR) genes in environmental ecosystems. The researchers detected signals of resistance to common antimicrobial drugs and pinpointed hotspots of antimicrobial resistance โ€œsuperbugโ€. These results offer a complementary tool for surveillance to inform targeted interventions, bridging the One Health gap created by the traditional focus on clinical surveillance, often overlooking the environmental reservoirs of AMR. "Using advanced genomic tools, we tested local wastewater and uncovered a hidden landscape of AMR threats. This environmental surveillance approach provides an early warning tool for public health." Jackson Claver, Head of Genomics Department, NPHL.
Dr Vito Baraka, Principal Scientist and lead Investigator in Tanzania, explained that โ€œWES of pathogens and AMR is a radar of population health, what goes down our drains tells a story about our community health. This wastewater and environmental based surveillance provide a complementary tool for detecting early signals in our communities including AMR threats, informing targeted public health interventions, and protecting our communities. The approach is effective, empowering preventive actions and enabling us to take precise measures to safeguard our antimicrobial agents.โ€
Dr Eric Lyimo, co-Investigator in the study highlighted that: "AMR doesn't respect boundaries, and its cross-cutting issue that need multisectoral and multidisciplinary approach. AMR genes from farms, hospitals, and households can mix in our wasteways and environment. Therefore, protecting our antibiotics requires a integrated approach across through One Health concept, cutting across all sectors including human, veterinary and agriculture and environmental ecosystems."
The ODIN project, funded by the European & Developing Countries Clinical Trials Partnership (EDCTP3), is a multinational initiative. The ODIN Consortium brings together North-South partners and integrates high-capacity genomic technologies to advance wastewater surveillance for public health impact. The consortium brings together partners from the National Institute for Medical Research (NIMR) and National Public Health Laboratory (NPHL) in Tanzania, the University of Kinshasa (UNIKIN) in DR Congo, and the Institut de Recherche en Sciences de la Santรฉ (IRSS) in Burkina Faso together with NORCE (Norway), VIB-UGent (Belgium), the TGHN University of Oxford's Global Health Network (UK), the Finnish Institute for Health and Welfare (THL), and Lund University, Sweden. This collaborative platform is dedicated to exchanging technological innovation, strengthening capacity, advancing methodological approaches in WES and translating pathogen genomic data into actionable public health intelligence. This collaborative model ensures that surveillance tools are co-developed, context-specific and validated within the local settings. The project also focused on capacity strengthening to create and strengthen a scalable blueprint for WES across sub-Saharan Africa. . # ODIN

10/12/2025
07/12/2025
๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐˜„๐—ฎ๐—ท๐—ฒ๐—ป๐—ด๐—ฒ๐—ฎ ๐—จ๐˜„๐—ฒ๐˜‡๐—ผ ๐—ช๐—ฎ๐˜๐˜‚๐—บ๐—ถ๐˜€๐—ต๐—ถ ๐˜„๐—ฎ ๐—”๐—ณ๐˜†๐—ฎ ๐—ง๐—ฒ๐—บ๐—ฒ๐—ธ๐—ฒ ๐—ž๐˜‚๐—ฎ๐—ป๐—ฑ๐—ถ๐—ธ๐—ฎ ๐—”๐—ป๐—ฑ๐—ถ๐—ธ๐—ผ ๐—น๐—ฎ ๐—จ๐˜๐—ฎ๐—ณ๐—ถ๐˜๐—ถ ๐—ถ๐—น๐—ถ ๐—ž๐˜‚๐—ฏ๐—ผ๐—ฟ๐—ฒ๐˜€๐—ต๐—ฎ ๐—›๐˜‚๐—ฑ๐˜‚๐—บ๐—ฎ ๐˜‡๐—ฎ ๐—”๐—ณ๐˜†๐—ฎ ๐˜‡๐—ฎ ๐—๐—ฎ๐—บ๐—ถ๐—ถTaasisi y...
07/12/2025

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐˜„๐—ฎ๐—ท๐—ฒ๐—ป๐—ด๐—ฒ๐—ฎ ๐—จ๐˜„๐—ฒ๐˜‡๐—ผ ๐—ช๐—ฎ๐˜๐˜‚๐—บ๐—ถ๐˜€๐—ต๐—ถ ๐˜„๐—ฎ ๐—”๐—ณ๐˜†๐—ฎ ๐—ง๐—ฒ๐—บ๐—ฒ๐—ธ๐—ฒ ๐—ž๐˜‚๐—ฎ๐—ป๐—ฑ๐—ถ๐—ธ๐—ฎ ๐—”๐—ป๐—ฑ๐—ถ๐—ธ๐—ผ ๐—น๐—ฎ ๐—จ๐˜๐—ฎ๐—ณ๐—ถ๐˜๐—ถ ๐—ถ๐—น๐—ถ ๐—ž๐˜‚๐—ฏ๐—ผ๐—ฟ๐—ฒ๐˜€๐—ต๐—ฎ ๐—›๐˜‚๐—ฑ๐˜‚๐—บ๐—ฎ ๐˜‡๐—ฎ ๐—”๐—ณ๐˜†๐—ฎ ๐˜‡๐—ฎ ๐—๐—ฎ๐—บ๐—ถ๐—ถ

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR), kupitia Kituo chake cha Muhimbili, imeendesha mafunzo maalumu ya uandishi wa andiko la kitafiti kwa watumishi wa afya kutoka Hospitali ya Rufaa ya Mkoa Temeke. Mafunzo hayo ya siku tatu, yaliyofanyika kuanzia tarehe 26 hadi 28 Novemba 2025, yalilenga kuwajengea uwezo washiriki katika kubuni, kuandaa na kuwasilisha mapendekezo bora ya tafiti za kisayansi.
Katika mafunzo hayo, washiriki walipata fursa ya kufanya mazoezi kwa vitendo kuhusu hatua muhimu za uandishi wa andiko la utafiti, ikiwemo kuandaa mapendekezo yenye ubora, kuimarisha uwezo wa uandishi wa kisayansi, kuelewa na kutekeleza maadili ya utafiti, pamoja na kubadilisha mawazo ya kitaalamu na kuwa tafiti zenye matokeo chanya na zinazoweza kupata ufadhili.
Akizungumza wakati wa kufunga mafunzo hayo kwa niaba ya Mkurugenzi Mkuu, Mkurugenzi wa Kukuza na Kuratibu Tafiti NIMR (DRCP) Dkt. Nyanda E. Ntinginya, ameushukuru uongozi wa Hospitali ya Temeke kwa kuthamini umuhimu wa mafunzo hayo na kuhakikisha ushiriki mpana wa watumishi wake. Amesisitiza kuwa ujuzi walioupata washiriki unapaswa kutumika kuboresha utoaji wa huduma za afya kwa kuanzisha, kuendesha na kuchapisha tafiti zenye manufaa kwa wananchi na taifa kwa ujumla.
Dkt. Nyanda pia alibainisha kuwa NIMR itaendelea kuimarisha ushirikiano na Hospitali ya Rufaa ya Temeke katika kukuza uwezo wa watumishi, kuendeleza tafiti za pamoja na kuhamasisha matumizi ya ushahidi wa kisayansi katika kuboresha huduma za afya nchini.
Mafunzo hayo yanaibua matumaini mapya kwa watumishi wa afya Temeke, huku yakitarajiwa kuongeza ubunifu, ushindani na tija katika uandaaji wa tafiti zenye mchango mkubwa katika mfumo wa afya wa Tanzania.

๐๐ˆ๐Œ๐‘ ๐ƒ๐ข๐ฌ๐ฌ๐ž๐ฆ๐ข๐ง๐š๐ญ๐ž๐ฌ ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ๐Ÿ๐ฎ๐ฅ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐…๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐š๐ญ ๐ญ๐ก๐ž ๐Ÿ•๐ญ๐ก  ๐€๐Ÿ๐ซ๐ข๐œ๐š ๐‚๐จ๐ง๐ญ๐ข๐ง๐ž๐ง๐ญ๐š๐ฅ ๐–๐จ๐ซ๐ฅ๐ ๐€๐Œ๐‘ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐–๐ž๐ž๐ค.In a milestone eve...
06/12/2025

๐๐ˆ๐Œ๐‘ ๐ƒ๐ข๐ฌ๐ฌ๐ž๐ฆ๐ข๐ง๐š๐ญ๐ž๐ฌ ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ๐Ÿ๐ฎ๐ฅ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐…๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐š๐ญ ๐ญ๐ก๐ž ๐Ÿ•๐ญ๐ก ๐€๐Ÿ๐ซ๐ข๐œ๐š ๐‚๐จ๐ง๐ญ๐ข๐ง๐ž๐ง๐ญ๐š๐ฅ ๐–๐จ๐ซ๐ฅ๐ ๐€๐Œ๐‘ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐–๐ž๐ž๐ค.

In a milestone event for the continent, Tanzania hosted the 7th Africa Continental World Antimicrobial Resistance (AMR) Awareness Week (WAAW) at the Hyatt Regency Hotel in Dar es Salaam from 2nd to 5th December 2025, reaffirming its commitment to combating AMR. The theme of WAAW was โ€œAct Now: Protect Our Present, Secure Our Futureโ€. The event, inaugurated by his excellency Ambassador Dr. Emmanuel John Nchimbi, the Vice President of United Republic of Tanzania on behalf of H.E. President Dr. Samia Suluhu Hassan was attended by policymakers, research scientists, academicians, youth leaders and international partners to exchange knowledge, strengthen collaborations, and accelerate actionable solutions to the growing AMR threat.
The National Institute for Medical Research (NIMR) played an important role in the success of the week-long continental Africa commemoration. As a member of the National Multisectoral Coordinating Committee on AMR and part of the event organizing committee, NIMR contributed to shaping the agenda, coordinating sessions, and driving discussions that bridged policy, science, and practice.
NIMR scientists presented ten key studies covering clinical and environmental aspects of AMR.
NIMR research scientists presented ten key studies covering clinical and environmental aspects of AMR. Highlights included Wastewater and Environmental Surveillance for Pathogen Detection and Antimicrobial Resistance Gene Profiling in Tanzania, Molecular Characterization of Extended-Spectrum-Beta- Lactamase-Producing Klebsiella pneumoniae among children and chickens in Korogwe District, Prevalence, Diagnostic Accuracy, and Antimicrobial Resistance Patterns of Uropathogens in Urinary Tract Infections at Ngamiani Health Center in Tanga, Prevalence and Antimicrobial Resistance Profiles of ESKAPE pathogens isolated from clinical samples in Tanga City, Laboratory-Based Surveillance of Antimicrobial Resistance in Urinary Tract Pathogens at Bombo Regional Referral Hospital, Tanga Region, and The Prevalence of Multi-Drug Resistant Salmonella typhi Isolated from Blood Samples at Selected Health Facilities in Korogwe District, Tanga.
Additional presentations showcased environmental and hospital-based surveillance, including Multidrug-Resistant Bacteria Contamination on Highly Touched Surfaces among the Public Transports in Tanga City, North-Eastern Tanzania, Molecular Epidemiology and Antimicrobial Resistance of Extended-Spectrum Beta-Lactamase-Producing Enterobacter cloacae Complex in Neonatal Units in Tanga, and Emerging Antimicrobial Resistance among Bloodstream Infections at Tanga Regional Referral Hospital and Ngamiani Health Centre: A 2023โ€“2025 Surveillance Study. The EXPAND-AMR study, led by Professor John Lusingu, Principal Investigator at NIMR Tanga, provided critical insights into overdiagnosis of urinary tract infections and associated antibiotic resistance, demonstrating actionable strategies for improved diagnostics and treatment.
Through its engagement, NIMR reinforced the One Health approach, integrating human, animal, agriculture, and environmental health perspectives while delivering evidence-based recommendations to protect Tanzaniaโ€™s antibiotic resources. By showcasing scientific leadership and strategic direction, NIMR strengthens Tanzaniaโ€™s position at the forefront of AMR research, policy development, and continental collaboration.
The event underscored that combating AMR requires robust laboratory infrastructure, accurate diagnostics, evidence-based treatment, and integrated One Health strategies. NIMR continues to translate research into actionable policy, safeguarding public health in Tanzania and across Africa.
Other participants from NIMR included Dr. Vito Baraka, Principal Scientist and Lead Investigator of the ODIN project; Dr. Eric Lyimo, Co-Investigator of the ODIN project; and Mr. Athanas Mhina, Laboratory Technologist. Other key NIMR contributors and scientists who actively organized, presented, and facilitated sessions throughout the event also participated, demonstrating the instituteโ€™s comprehensive engagement at all levels of the continental WAAW 2025 event.

๐—ก๐—œ๐— ๐—ฅ ๐—–๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐˜€ ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—•๐—ผ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ง๐—ฟ๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—˜๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ฒ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ก๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜„๐—ถ๐—ฑ๐—ฒThe National Institute ...
02/12/2025

๐—ก๐—œ๐— ๐—ฅ ๐—–๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐˜€ ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—•๐—ผ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ง๐—ฟ๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—˜๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ฒ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ก๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜„๐—ถ๐—ฑ๐—ฒ

The National Institute for Medical Research (NIMR) has launched a specialized training program to members and secretariats of Institutional Review Boards (IRBs), aimed at strengthening national capacity to oversee clinical trials in line with the highest scientific and ethical standards. This is the second training after the first one which was conducted to clinical trial researchers from 24th to 26th November 2025 as part of the similar initiative of the project.
Speaking during the official opening of the training, NIMR Director General, Prof. Said Aboud, said the initiative forms part of the national strategy to enhance the countryโ€™s clinical research framework at a time when rapid technological advancements and the growth of health research demand robust ethical and regulatory systems. He emphasized that the training is designed to enhance the efficiency of IRBs in receiving, analyzing, and reviewing research proposals involving human participants, while ensuring that rights, safety, and welfare of trial participants are fully protected.
Providing an overview of the training, Dr. Obadia Bishoge, Coordinator of the TRACE Project and Deputy Secretary of the National Health Research Ethics Committee (NatHREC), explained that the initiative is part of the implementation of the TRACE (Trial Regulation and Clinical Ethics Optimization) Project, which is being carried out in Tanzania, Rwanda, Zimbabwe, and Nigeria with funding from the Gates Foundation. He noted that the project aims to transform Africaโ€™s currently fragmented and largely manual ethics and regulatory systems into harmonized, efficient, and digitally supported processes.
Dr. Bishoge further outlined that TRACE seeks to build capacity for national ethics committees and regulatory agencies, harmonize policies and guidelines to align with regional and international standards, strengthen digital systems such as RIMS and NREIMS to streamline submissions and reviews, and enhance clinical trial oversight through improved GCP and GCLP monitoring, reporting, and inspections. He added that the project also intends to support IRBs in securing accreditation and strengthening the financial sustainability of the ethics review model.
Prof. Aboud further noted that Tanzaniaโ€™s ethics system operates through coordinated roles of the NIMR Medical Research Coordinating Committee (MRCC), NatHREC, and delegated accredited IRBs at institutional levels, ensuring that ethical oversight is effectively implemented from institutional to national platform.
The two-day training, organized by NIMR in collaboration with TMDA, focuses on strengthening participantsโ€™ understanding of ethical issues in clinical research, identifying and mitigating potential risks, ensuring fair benefit-sharing, preventing research misconduct and improving overall quality in the conduct of clinical trials. Participants were drawn from various IRBs across the country and were taken through key thematic areas including Overview of Clinical Trial Regulation and Oversight in Tanzania, Accreditation Requirements and Processes for IRECs/IRBs, Workflow Optimization to Reduce Review and Approval Timelines; Effective Review of Clinical Trial Protocols: Ethical and Scientific Considerations, NatHREC SOPs, and the Handling of Notifications, SAE, and SUSAR Reports.
Participants are expected to return to their institutions with enhanced knowledge that will improve integrity, transparency, and efficiency within the national clinical trial ecosystem. This training marks a significant milestone in building a trustworthy and globally competitive clinical trial environment in Tanzania.

๐€ ๐ฆ๐š๐ฃ๐จ๐ซ ๐ฌ๐ญ๐ž๐ฉ ๐Ÿ๐จ๐ซ๐ฐ๐š๐ซ๐ ๐ข๐ง ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐‘๐ž๐ฌ๐ข๐ฅ๐ข๐ž๐ง๐œ๐ž ๐š๐ ๐š๐ข๐ง๐ฌ๐ญ ๐‚๐ฅ๐ข๐ฆ๐š๐ญ๐ž ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ๐ฌOur DANIDA-funded consortium of mu...
29/11/2025

๐€ ๐ฆ๐š๐ฃ๐จ๐ซ ๐ฌ๐ญ๐ž๐ฉ ๐Ÿ๐จ๐ซ๐ฐ๐š๐ซ๐ ๐ข๐ง ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐‘๐ž๐ฌ๐ข๐ฅ๐ข๐ž๐ง๐œ๐ž ๐š๐ ๐š๐ข๐ง๐ฌ๐ญ ๐‚๐ฅ๐ข๐ฆ๐š๐ญ๐ž ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ๐ฌ

Our DANIDA-funded consortium of multidisciplinary experts is proud to launch an Early Warning System (EWAS) modelling tool designed to predict and prevent outbreaks of malaria and other mosquito-borne diseases driven by climate variability.
This initiativeโ€”led by NIMR, SUZA and the University of Dar es Salaam (UDSM), in close collaboration with KCRI, the National Malaria Control Programme (NMCP), the Zanzibar Malaria Elimination Programme (ZAMEP), and international partnersโ€”integrates a predictive model into Tanzaniaโ€™s national health system (DHIS2).
This marks a promising paradigm shift: from reactive response to proactive and targeted prevention, safeguarding communities and strengthening sustainable, climate-resilient health systems.
Sincere thanks and congratulations to all DANIDAโ€“PreVBD project partners, our dedicated staff, longstanding collaborators, and everyone who contributed their expertise to this milestone.
A powerful testament to collaboration, local leadership, and global partnership in addressing the pressing challenges at the intersection of climate and health.

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ฒ๐—ป๐—ฑ๐—ฒ๐˜€๐—ต๐—ฎ ๐— ๐—ฎ๐—ณ๐˜‚๐—ป๐˜‡๐—ผ ๐—ž๐˜‚๐˜„๐—ฎ๐—ท๐—ฒ๐—ป๐—ด๐—ฒ๐—ฎ ๐—จ๐˜„๐—ฒ๐˜‡๐—ผ ๐—ช๐—ฎ๐˜๐—ฎ๐—ณ๐—ถ๐˜๐—ถ ๐˜„๐—ฎ ๐— ๐—ฎ๐—ท๐—ฎ๐—ฟ๐—ถ๐—ฏ๐—ถ๐—ผ ๐˜†๐—ฎ ๐—ž๐—ถ๐˜๐—ฎ๐—ฏ๐—ถ๐—ฏ๐˜‚Taasisi ya Taifa ya Utafiti wa Magonjwa ya Bina...
26/11/2025

๐—ก๐—œ๐— ๐—ฅ ๐—ฌ๐—ฎ๐—ฒ๐—ป๐—ฑ๐—ฒ๐˜€๐—ต๐—ฎ ๐— ๐—ฎ๐—ณ๐˜‚๐—ป๐˜‡๐—ผ ๐—ž๐˜‚๐˜„๐—ฎ๐—ท๐—ฒ๐—ป๐—ด๐—ฒ๐—ฎ ๐—จ๐˜„๐—ฒ๐˜‡๐—ผ ๐—ช๐—ฎ๐˜๐—ฎ๐—ณ๐—ถ๐˜๐—ถ ๐˜„๐—ฎ ๐— ๐—ฎ๐—ท๐—ฎ๐—ฟ๐—ถ๐—ฏ๐—ถ๐—ผ ๐˜†๐—ฎ ๐—ž๐—ถ๐˜๐—ฎ๐—ฏ๐—ถ๐—ฏ๐˜‚

Taasisi ya Taifa ya Utafiti wa Magonjwa ya Binadamu (NIMR), kwa ushirikiano na Mamlaka ya Dawa na Vifaa Tiba (TMDA) leo tarehe 24/11/2025 imeendesha mafunzo maalumu ya kuwajengea uwezo watafiti wa Majaribio ya Kitabibu (Clinical Trials) kupitia Mradi wa โ€œTrial Regulation and Clinical Ethics Optimization (TRACE) in Africaโ€.
Akizungumza wakati wa kufungua mafunzo hayo ya siku tatu, Mkurugenzi Mkuu wa NIMR Prof. Said Aboud amesema kuwa majaribio ya kitabibu yanakuwa magumu zaidi kadri teknolojia inavyoendelea kukua na hivyo kuhitaji wataalamu waliopewa elimu ya kutosha pamoja na mifumo madhubuti ya kusimamia maadili na kurekebu.
Prof. Said Aboud amesisitiza kuwa dhamira ya NIMR ni kuendelea kuimarisha mfumo wa kitaifa wa tafiti za kitabibu ili uendane na mahitaji ya sasa ya kisayansi na viwango vya kimataifa.
โ€œMafunzo haya siyo ya darasani tu. Yamebeba mbinu shirikishi ikiwemo mazoezi ya mifano halisi na uchambuzi wa matukio ili kuimarisha uwezo wa kufanya maamuzi, kutambua mapungufu ya kimaadili na kufuata matakwa ya urekebu wa tafiti,โ€ ameongeza Prof. Aboud.
Mradi wa TRACE unalenga kuleta matokeo makuu manne, ambayo ni Kuimarishwa kwa uwezo wa kusimamia maadili na urekebu, kuongeza ufanisi na kasi ya mapitio ya maombi ya tafiti za kitabibu, Kuboresha ubora wa usimamizi na ufuatiliaji wa tafiti, kuongeza mashirikiano, upatikanaji wa taarifa na athari chanya za tafiti nchini.
Prof. Aboud amewahimiza washiriki kutumia ipasavyo mafunzo hayo na kurejea katika taasisi zao wakiwa mabalozi wazuri na wa viwango vya juu vya kitaalamu katika utekelezaji wa tafiti za kitabibu.
.

Address

3 Barack Obama Drive
Dar Es Salaam
P.O.BOX9653

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Friday 08:00 - 16:00

Alerts

Be the first to know and let us send you an email when National Institute For Medical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to National Institute For Medical Research:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram